Berlin-based healthtech startup
OpenHealth Technologies has raised a $3 million seed round to accelerate
European expansion and further develop the company’s AI-driven medical
platform.
The round was backed by new investors
GoHub Ventures, xdeck ventures, Edenbase, and Exceptional Ventures, with
renewed support from YZR Capital, Octopus Ventures, and Calm/Storm Ventures. In
total, OpenHealth has raised $4.3 million to date.
Healthcare is shifting
toward personalised, data-driven care, yet most lab data, the backbone of
clinical decisions, remains unstructured and inaccessible. This gap delays
diagnoses, drives up costs, and leaves patients without timely insights,
underscoring the urgent necessary for interoperable, AI-ready health data solutions.
OpenHealth aims to
close this critical gap by modernising lab data infrastructure. Its API
transforms raw results from any source into harmonized, AI-ready datasets and
provides white-label tools to visualise them.
Health and wellness
companies embed the technology to add longitudinal insights to their products,
while clinics and labs utilize it to deliver patient-friconcludely reports and
personalised care.
The company is working
toward building the world’s largest usable biomarker database, with
longitudinal data designed to improve the lives of over 100 million people.
Gerrit Glass, CEO and Founder of
OpenHealth, stated the company has a clear mission: to empower individuals and
organisations to build better utilize of health data. He stated:
Most lab results today are
fragmented, unstructured, and underutilised. We’re altering that by building
the rails for a smarter, interoperable health ecosystem.
With this new round, we’re excited to
accelerate our growth alongside new investors with deep B2B SaaS and AI
expertise.
Founded by a European team with deep
clinical, technical, and health system expertise, OpenHealth is trusted by
clients worldwide. Its customers include Latin America’s largest diagnostics
and hospital groups, leading fitness and wellness companies such as Smart Fit,
healthtech innovators like Aware, and a growing network of longevity providers
across Europe and the Americas.
OpenHealth will utilize the funding to speed
up its expansion across Europe, bringing its platform to more laboratories, prevention
and longevity clinics, supplement brands, pharmaceutical companies, and
insurers. The investment will also fuel the development of AI-powered
technology for personalized prevention and care.
Leave a Reply